Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amber Salter

Showing results (11-20 of 232) with videos related to

Pageof 24
Sort By:
Neurologic Clinics|November 18, 2023
Era of COVID-19 in Multiple Sclerosis CareJonathan D Krett, Amber Salter, Scott D Newsome
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 8, 2016
Declines in the diagnosis of primary progressive MS: A critical change in phenotype or critical measurement error?Gary R Cutter, Amber Salter, Ruth Ann Marrie
Therapeutic Advances in Neurological Disorders|July 24, 2018
Clinical trials in multiple sclerosis: milestonesYinan Zhang, Amber Salter, Gary Cutter, et al.
Multiple Sclerosis and Related Disorders|April 21, 2024
Focusing on neural mechanisms of exercise training benefits in multiple sclerosisBrian M Sandroff, Robert W Motl, Amber Salter
International Journal of MS Care|January 30, 2023
A Systematic Review of the Validity and Reliability of the Patient-Determined Disease Steps ScaleRuth Ann Marrie, Caitlin McFadyen, Lauren Yaeger, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|June 17, 2017
Assessment of disease aggression in cystic pancreatic neuroendocrine tumors: A CT and pathology correlation studyMotoyo Yano, Sunil Misra, Amber Salter, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 22, 2020
Adverse event profile differences between rituximab and ocrelizumab: Findings from the FDA Adverse Event Reporting DatabaseNatalia Gonzalez Caldito, Afsaneh Shirani, Amber Salter, et al.
Abdominal Radiology (New York)|February 22, 2019
CT IVC venogram: normalized quantitative criteria for patency and thrombosisMarina Mityul, David J Kim, Amber Salter, et al.
Neurology. Clinical Practice|September 2, 2025
Strategies for Improving Access in Academic NeurologyJaya Trivedi, Amber Salter, Debra Clamp, et al.
Therapeutic Advances in Neurological Disorders|March 6, 2019
Evolution of clinical trials in multiple sclerosisYinan Zhang, Amber Salter, Erik Wallström, et al.
Pageof 24

Showing results (11-20 of 232) with videos related to

Sort By:
Pageof 24
Neurologic Clinics|November 18, 2023
Era of COVID-19 in Multiple Sclerosis CareJonathan D Krett, Amber Salter, Scott D Newsome
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 8, 2016
Declines in the diagnosis of primary progressive MS: A critical change in phenotype or critical measurement error?Gary R Cutter, Amber Salter, Ruth Ann Marrie
Therapeutic Advances in Neurological Disorders|July 24, 2018
Clinical trials in multiple sclerosis: milestonesYinan Zhang, Amber Salter, Gary Cutter, et al.
Multiple Sclerosis and Related Disorders|April 21, 2024
Focusing on neural mechanisms of exercise training benefits in multiple sclerosisBrian M Sandroff, Robert W Motl, Amber Salter
International Journal of MS Care|January 30, 2023
A Systematic Review of the Validity and Reliability of the Patient-Determined Disease Steps ScaleRuth Ann Marrie, Caitlin McFadyen, Lauren Yaeger, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|June 17, 2017
Assessment of disease aggression in cystic pancreatic neuroendocrine tumors: A CT and pathology correlation studyMotoyo Yano, Sunil Misra, Amber Salter, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 22, 2020
Adverse event profile differences between rituximab and ocrelizumab: Findings from the FDA Adverse Event Reporting DatabaseNatalia Gonzalez Caldito, Afsaneh Shirani, Amber Salter, et al.
Abdominal Radiology (New York)|February 22, 2019
CT IVC venogram: normalized quantitative criteria for patency and thrombosisMarina Mityul, David J Kim, Amber Salter, et al.
Neurology. Clinical Practice|September 2, 2025
Strategies for Improving Access in Academic NeurologyJaya Trivedi, Amber Salter, Debra Clamp, et al.
Therapeutic Advances in Neurological Disorders|March 6, 2019
Evolution of clinical trials in multiple sclerosisYinan Zhang, Amber Salter, Erik Wallström, et al.
Pageof 24